Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-28 Option Award | 2023-12-29 5:24 pm | N/A 2033-12-28 | Actinium Pharmaceuticals Inc. | ATNM | Nicholson C. David Director | 70,311 | $0 | 70,311 (Direct) | View |
| 2023-12-28 Option Award | 2023-12-29 5:23 pm | N/A 2033-12-28 | Actinium Pharmaceuticals Inc. | ATNM | Steinhart Richard I Director | 70,311 | $0 | 70,311 (Direct) | View |
| 2023-12-28 Option Award | 2023-12-29 5:20 pm | N/A 2033-12-28 | Actinium Pharmaceuticals Inc. | ATNM | O'Loughlin Steve Chief Financial Officer | 253,123 | $0 | 253,123 (Direct) | View |
| 2023-12-28 Option Award | 2023-12-29 5:18 pm | N/A 2033-12-28 | Actinium Pharmaceuticals Inc. | ATNM | Shetty Ajit Director | 70,311 | $0 | 70,311 (Direct) | View |
| 2023-12-28 Option Award | 2023-12-29 5:17 pm | N/A 2033-12-28 | Actinium Pharmaceuticals Inc. | ATNM | SETH SANDESH Chief Executive Officer | 984,367 | $0 | 984,367 (Direct) | View |
| 2023-12-28 Option Award | 2023-12-29 5:15 pm | N/A 2033-12-28 | Actinium Pharmaceuticals Inc. | ATNM | Chell Jeffrey W. Director | 70,311 | $0 | 70,311 (Direct) | View |
| 2022-08-17 Option Award | 2022-08-19 4:55 pm | N/A N/A | Actinium Pharmaceuticals Inc. | ATNM | SETH SANDESH Chief Executive Officer | 300,000 | $0 | 305,381 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-01 7:19 pm | N/A 2032-07-01 | Actinium Pharmaceuticals Inc. | ATNM | O'Loughlin Steve Chief Financial Officer | 256,438 | $0 | 256,348 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-01 7:17 pm | N/A 2032-07-01 | Actinium Pharmaceuticals Inc. | ATNM | Nicholson C. David Director | 72,156 | $0 | 72,156 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-01 7:16 pm | N/A 2032-07-01 | Actinium Pharmaceuticals Inc. | ATNM | Steinhart Richard I Director | 72,156 | $0 | 72,156 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-01 7:14 pm | N/A 2032-07-01 | Actinium Pharmaceuticals Inc. | ATNM | Shetty Ajit Director | 72,156 | $0 | 72,156 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-01 7:13 pm | N/A 2032-07-01 | Actinium Pharmaceuticals Inc. | ATNM | SETH SANDESH Chief Executive Officer | 827,366 | $0 | 827,366 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-01 7:11 pm | N/A 2032-07-01 | Actinium Pharmaceuticals Inc. | ATNM | Chell Jeffrey W. Director | 72,156 | $0 | 72,156 (Direct) | View |
| 2021-09-01 Option Award | 2021-09-03 5:05 pm | N/A 2031-09-01 | Actinium Pharmaceuticals Inc. | ATNM | Chell Jeffrey W. Director | 18,351 | $0 | 18,351 (Direct) | View |
| 2021-09-01 Option Award | 2021-09-03 5:04 pm | N/A 2031-09-01 | Actinium Pharmaceuticals Inc. | ATNM | Berger Mark Stanley Chief Medical Officer | 67,164 | $0 | 67,164 (Direct) | View |
| 2021-09-01 Option Award | 2021-09-03 5:03 pm | N/A 2031-09-01 | Actinium Pharmaceuticals Inc. | ATNM | Shetty Ajit Director | 18,351 | $0 | 18,351 (Direct) | View |
| 2021-09-01 Option Award | 2021-09-03 5:02 pm | N/A 2031-09-01 | Actinium Pharmaceuticals Inc. | ATNM | O'Loughlin Steve Chief Financial Officer | 107,463 | $0 | 107,463 (Direct) | View |
| 2021-09-01 Option Award | 2021-09-03 5:02 pm | N/A 2031-09-01 | Actinium Pharmaceuticals Inc. | ATNM | Steinhart Richard I Director | 18,351 | $0 | 18,351 (Direct) | View |
| 2021-09-01 Option Award | 2021-09-03 5:01 pm | N/A 2031-09-01 | Actinium Pharmaceuticals Inc. | ATNM | SETH SANDESH Chief Executive Officer | 310,182 | $0 | 310,182 (Direct) | View |
| 2021-09-01 Option Award | 2021-09-03 5:00 pm | N/A 2031-09-01 | Actinium Pharmaceuticals Inc. | ATNM | Nicholson C. David Director | 18,351 | $0 | 18,351 (Direct) | View |
| 2020-08-12 Option Award | 2020-08-14 5:21 pm | N/A 2030-08-12 | Actinium Pharmaceuticals Inc. | ATNM | O'Loughlin Steve Chief Financial Officer | 59,066 | $0 | 59,066 (Direct) | View |
| 2020-08-12 Option Award | 2020-08-14 5:21 pm | N/A 2030-08-12 | Actinium Pharmaceuticals Inc. | ATNM | SETH SANDESH Chief Executive Officer | 139,062 | $0 | 139,062 (Direct) | View |
| 2020-08-12 Option Award | 2020-08-14 5:18 pm | N/A 2030-08-12 | Actinium Pharmaceuticals Inc. | ATNM | Chell Jeffrey W. Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2020-08-12 Option Award | 2020-08-14 5:17 pm | N/A 2030-08-12 | Actinium Pharmaceuticals Inc. | ATNM | Berger Mark Stanley Chief Medical Officer | 46,667 | $0 | 46,667 (Direct) | View |
| 2020-08-12 Option Award | 2020-08-14 5:03 pm | N/A 2030-08-12 | Actinium Pharmaceuticals Inc. | ATNM | Steinhart Richard I Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2020-08-12 Option Award | 2020-08-14 5:03 pm | N/A 2030-08-12 | Actinium Pharmaceuticals Inc. | ATNM | Shetty Ajit Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2020-08-12 Option Award | 2020-08-14 5:03 pm | N/A 2030-08-12 | Actinium Pharmaceuticals Inc. | ATNM | Ludwig Dale L. Chief Science & Tech. Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2020-08-12 Option Award | 2020-08-14 5:02 pm | N/A 2030-08-12 | Actinium Pharmaceuticals Inc. | ATNM | Nicholson C. David Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2019-07-12 Option Award | 2019-07-16 5:19 pm | N/A 2029-07-12 | Actinium Pharmaceuticals Inc. | ATNM | Steinhart Richard I Director | 250,000 | $0.232 | 250,000 (Direct) | View |
| 2019-07-12 Option Award | 2019-07-16 5:16 pm | N/A 2029-07-12 | Actinium Pharmaceuticals Inc. | ATNM | Chell Jeffrey W. Director | 250,000 | $0.232 | 250,000 (Direct) | View |
| 2019-07-12 Option Award | 2019-07-16 5:13 pm | 2019-07-12 2029-07-12 | Actinium Pharmaceuticals Inc. | ATNM | Ludwig Dale L. Chief Scientific Officer | 400,000 | $0.232 | 400,000 (Direct) | View |
| 2019-07-12 Option Award | 2019-07-16 5:10 pm | 2019-07-12 2029-07-12 | Actinium Pharmaceuticals Inc. | ATNM | O'Loughlin Steve Principal Financial Officer | 400,000 | $0.232 | 400,000 (Direct) | View |
| 2019-07-12 Option Award | 2019-07-16 5:07 pm | 2019-07-12 2029-07-12 | Actinium Pharmaceuticals Inc. | ATNM | Berger Mark Stanley Chief Medical Officer | 400,000 | $0.232 | 400,000 (Direct) | View |
| 2019-07-12 Option Award | 2019-07-16 5:02 pm | 2019-07-12 2029-07-12 | Actinium Pharmaceuticals Inc. | ATNM | SETH SANDESH CEO | 1,500,000 | $0.232 | 1,500,000 (Direct) | View |
| 2019-07-12 Option Award | 2019-07-16 4:59 pm | 2019-07-12 2029-07-12 | Actinium Pharmaceuticals Inc. | ATNM | Kapur Anil Chief Commercial Officer | 400,000 | $0.232 | 400,000 (Direct) | View |
| 2019-07-12 Option Award | 2019-07-16 4:58 pm | N/A 2029-07-12 | Actinium Pharmaceuticals Inc. | ATNM | Shetty Ajit Director | 250,000 | $0.232 | 250,000 (Direct) | View |
| 2019-07-12 Option Award | 2019-07-16 4:55 pm | N/A 2029-07-12 | Actinium Pharmaceuticals Inc. | ATNM | Nicholson C. David Director | 250,000 | $0.232 | 250,000 (Direct) | View |